Total Payments
$56,987
2024 Payments
$1,611
Companies
6
Transactions
81
Medicare Patients
946
Medicare Billing
$109,919
Payment Breakdown by Category
Consulting$27,080 (47.5%)
Other$21,587 (37.9%)
Travel$6,840 (12.0%)
Food & Beverage$1,361 (2.4%)
Education$118.40 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,080 | 15 | 47.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,187 | 6 | 24.9% |
| Honoraria | $7,400 | 2 | 13.0% |
| Travel and Lodging | $6,840 | 29 | 12.0% |
| Food and Beverage | $1,361 | 26 | 2.4% |
| Education | $118.40 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $43,657 | 71 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $7,726 | 4 | $0 (2022) |
| HRA PHARMA RARE DISEASES | $4,600 | 2 | $0 (2022) |
| PFIZER INC. | $880.00 | 1 | $0 (2019) |
| Novo Nordisk Inc | $68.15 | 2 | $0 (2019) |
| Amryt Pharma Holdings Ltd | $55.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,611 | 4 | Corcept Therapeutics ($1,611) |
| 2023 | $5,970 | 8 | Corcept Therapeutics ($5,970) |
| 2022 | $9,946 | 7 | Xeris Pharmaceuticals, Inc. ($5,926) |
| 2021 | $5,950 | 3 | Corcept Therapeutics ($4,150) |
| 2020 | $10,357 | 13 | Corcept Therapeutics ($6,957) |
| 2019 | $19,012 | 39 | Corcept Therapeutics ($18,064) |
| 2018 | $4,141 | 7 | Corcept Therapeutics ($4,141) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $637.50 | General |
| Category: Endocrinology | ||||||
| 06/18/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Endocrinology | ||||||
| 05/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Endocrinology | ||||||
| 03/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $94.31 | General |
| Category: Endocrinology | ||||||
| 12/20/2023 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $45.71 | General |
| Category: Endocrinology | ||||||
| 12/20/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Endocrinology | ||||||
| 11/27/2023 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $577.79 | General |
| Category: Endocrinology | ||||||
| 11/27/2023 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $390.16 | General |
| Category: Endocrinology | ||||||
| 11/27/2023 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | In-kind items and services | $358.44 | General |
| Category: Endocrinology | ||||||
| 11/27/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $41.31 | General |
| Category: Endocrinology | ||||||
| 11/15/2023 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,637.00 | General |
| Category: Endocrinology | ||||||
| 05/03/2023 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,900.00 | General |
| Category: Endocrinology | ||||||
| 12/20/2022 | HRA PHARMA RARE DISEASES | Metopirone (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Cushings Syndrome | ||||||
| 11/09/2022 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Endocrinology | ||||||
| 11/03/2022 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $64.49 | General |
| Category: Endocrinology | ||||||
| 10/07/2022 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $55.35 | General |
| Category: Endocrinology | ||||||
| 07/20/2022 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Honoraria | Cash or cash equivalent | $5,400.00 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/20/2022 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Travel and Lodging | Cash or cash equivalent | $508.46 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/20/2022 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/29/2021 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Endocrinology | ||||||
| 03/29/2021 | Corcept Therapeutics | Korlym (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Endocrinology | ||||||
| 03/15/2021 | Xeris Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 11/19/2020 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Endocrinology | ||||||
| 07/13/2020 | HRA Pharma Rare Diseases | Lysodren (Drug) | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| Category: Inoperable adrenal cortical carcinoma | ||||||
| 06/24/2020 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $1,662.50 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 233 | 266 | $70,404 | $26,055 |
| 2022 | 8 | 239 | 284 | $76,253 | $27,211 |
| 2021 | 6 | 250 | 320 | $92,978 | $33,139 |
| 2020 | 7 | 224 | 268 | $79,108 | $23,514 |
Total Patients
946
Total Services
1,138
Medicare Billing
$109,919
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 69 | $18,570 | $7,260 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $15,692 | $5,432 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 72 | $12,299 | $5,123 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 38 | $8,332 | $2,894 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $6,536 | $2,615 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,391 | $1,930 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $2,584 | $800.93 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 85 | $20,852 | $8,364 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $7,872 | $3,001 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 48 | $9,264 | $2,897 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 18 | $5,990 | $2,627 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 34 | $7,140 | $2,375 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,619 | $2,250 | 29.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,856 | $1,840 | 31.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $4,896 | $1,535 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,936 | $1,391 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,828 | $930.86 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 85 | $21,484 | $8,299 | 38.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 80 | $15,440 | $4,970 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 41 | $15,006 | $4,825 | 32.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 34 | $11,846 | $4,710 | 39.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $8,436 | $2,732 | 32.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $7,722 | $2,523 | 32.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $4,983 | $1,775 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 13 | $3,861 | $1,659 | 43.0% |
About Dr. Amir Hamrahian, MD
Dr. Amir Hamrahian, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033219340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Hamrahian, MD has received a total of $56,987 in payments from pharmaceutical and medical device companies, with $1,611 received in 2024. These payments were reported across 81 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($27,080).
As a Medicare-enrolled provider, Hamrahian has provided services to 946 Medicare beneficiaries, totaling 1,138 services with total Medicare billing of $109,919. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Cleveland, OH
- Active Since 09/25/2006
- Last Updated 02/06/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1033219340
Products in Payments
- Korlym (Drug) $43,657
- RECORLEV (Drug) $5,926
- Lysodren (Drug) $3,400
- Metopirone (Drug) $1,200
- SOMAVERT (Drug) $880.00
- Macrilen (Drug) $68.15
- MYCAPSSA (Drug) $55.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Cleveland
Kevin Pantalone, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Adi Mehta, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $216,001
Endocrinology, Diabetes & Metabolism $216,001
Dr. Allan Kennedy, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,447
Endocrinology, Diabetes & Metabolism $158,447
Christian Nasr, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $152,638
Endocrinology, Diabetes & Metabolism $152,638
Dr. Bartolome Burguera, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $92,204
Endocrinology, Diabetes & Metabolism $92,204
Robert Zimmerman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $58,659
Endocrinology, Diabetes & Metabolism $58,659